Aciclovir Mylan

Valsts: Jaunzēlande

Valoda: angļu

Klimata pārmaiņas: Medsafe (Medicines Safety Authority)

Nopērc to tagad

Aktīvā sastāvdaļa:

Aciclovir sodium 314.4mg equivalent to Aciclovir 250 mg

Pieejams no:

Viatris Limited

SNN (starptautisko nepatentēto nosaukumu):

Aciclovir sodium 314.4 mg (equivalent to Aciclovir 250 mg)

Deva:

250 mg

Zāļu forma:

Powder for infusion

Kompozīcija:

Active: Aciclovir sodium 314.4mg equivalent to Aciclovir 250 mg

Receptes veids:

Prescription

Ražojis:

Sequent Scientific Limited

Ārstēšanas norādes:

Aciclovir is indicated for the treatment of Herpes simplex infections. Aciclovir is indicated for the prophylaxis of Herpes simplex infections in immune-compromised patients. Aciclovir is indicated for the treatment of Varicella zoster infections. Aciclovir is indicated for the treatment of Herpes simplex infections in the neonate. Aciclovir infusion formulations are indicated for the prophylaxis of CMV infection in bone marrow transplant recipients. It has been shown that high dose intravenous aciclovir reduces the incidence and delays the onset of CMV infection. When high dose intravenous aciclovir is followed by 6 months treatment with high dose oral aciclovir (see prescribing information for oral aciclovir) mortality and the incidence of viraemia are also reduced.

Produktu pārskats:

Package - Contents - Shelf Life: Vial, glass, 10 mL Type 1 flint tubular glass vial with rubber closure and aluminium seal - 5 dose units - 24 months from date of manufacture stored at or below 25°C

Autorizācija datums:

2014-11-04

Meklēt brīdinājumus, kas saistīti ar šo produktu

Skatīt dokumentu vēsturi